NASDAQ · Health care

Synergy CHC Corp. (SNYR)

Synergy CHC Corp. brought in $5.9M of revenue over the twelve months to March 31, 2026, down 89.4% from a year earlier. It posted a net loss of $15.8M. At March 31, 2026 it held $292.1K in cash against $25M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on May 14, 2026.

Watch SNYR in 60 seconds

Price

$0.09

0.00% on the day · September 17, 2026

52-week range $0.02 to $2.90

Market cap

$1.3M

Revenue (last 12 months)

$5.9M

-89.4% year on year

Net margin

-268.8%

What Synergy CHC Corp. does

Synergy CHC Corp. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker SNYR.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	$30.4M	-$8.5M	-$12.3M	-$1.27	n/a
2024	$34.8M	$5.8M	$2.1M	$0.28	n/a
2024	$42.8M	$10.8M	$6.3M	$0.86	n/a
2019	$29.4M	-$8M	-$9.2M	-$0.10	n/a
2018	$33.8M	-$4.9M	-$6.2M	-$0.07	$1.2M
2017	$35.6M	$1.8M	$499.6K	$0.01	-$984.1K

Full financial statements: income, balance sheet and cash flow

Where SNYR ranks in Health care

Revenue$30.4M

#415 of 646 in Health care · Bottom 36%

Revenue growth-12.8%

#423 of 474 in Health care · Bottom 11%

Net margin-40.6%

#345 of 485 in Health care · Bottom 29%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

It paid out $1.2M in cash dividends.

Fiscal year	Per share	Paid out	Of profit
2015	n/a	$1.2M	n/a

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Synergy CHC Corp. has filed recently, newest first. Each links to the original document on SEC EDGAR.

September 16, 2026
Stock exchange listing notice 8-K
September 8, 2026
Bankruptcy or receivership 8-K
August 26, 2026
Debt repayment accelerated 8-K
August 21, 2026
Stock exchange listing notice 8-K
August 11, 2026
Debt repayment accelerated 8-K
July 29, 2026
Other event 8-K
June 29, 2026
Executive or director change 8-K
May 18, 2026
Stock exchange listing notice 8-K
May 15, 2026
IPO registration S-1
May 14, 2026
Quarterly results 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on July 1, 2026. Insider transactions on SEC

Insider trades

What the people running Synergy CHC Corp. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)

last 90 days

Sold

last 90 days

Date	Insider	What	Shares	Price	Value	Filing
April 21, 2026	Kaushal NitinDirector	Received as pay	306,433	-	-	Form 4
April 21, 2026	Thompson Teresa BrigidDirector	Received as pay	25,824	-	-	Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns SNYR

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

We have not read this company's Schedule 13D and 13G filings yet.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

2 insiders reported holding 332,257 shares in total, about $30.1K at the last price.

Holder	Shares	As of
Kaushal NitinDirector	306,433	April 21, 2026
Thompson Teresa BrigidDirector	25,824	April 21, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about SNYR

What does Synergy CHC Corp. do?

Synergy CHC Corp. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker SNYR.

Is Synergy CHC Corp. profitable?

No. Over the twelve months to March 31, 2026 it reported a net loss of $15.8M on revenue of $5.9M.

How much revenue does Synergy CHC Corp. make?

Over the twelve months to March 31, 2026 Synergy CHC Corp. reported revenue of $5.9M. That is 89.4% less than a year earlier.

When did Synergy CHC Corp. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on May 14, 2026. It covers the period to March 31, 2026. Its newest filing of any kind is the stock exchange listing notice from September 16, 2026.

Similar companies

TRLV

Trulieve Cannabis Corp.

SNDL

SNDL Inc.

USNA

Usana Health Sciences Inc

Compare SNYR with

Compare SNYR with any company

Follow SNYR

Get an email when Synergy CHC Corp. files with the SEC: results, executive changes, material agreements and annual reports.

Follow SNYR: get an email when it files

Where the numbers come from

Financial figures are the values Synergy CHC Corp. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.